During the past decade, JSC "Evex Hospitals' conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "JSC "Evex Hospitals'" are "Chronic Kidney Diseases" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "JSC "Evex Hospitals'" in a lesser frequency.

Most popular intervention types in "JSC "Evex Hospitals'" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cobitolimod 250 mg" (1 trials), "Cobitolimod 500 mg" (1 trials) and "KBP-5074" (1 trials). Other intervention names were less common.

The vast majority of trials in "JSC "Evex Hospitals'" are 2 trials for "All" genders.

Currently, there are NaN active trials in "JSC "Evex Hospitals'". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in JSC "Evex Hospitals', undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in JSC "Evex Hospitals', 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".